Published in Genes Chromosomes Cancer on May 01, 1998
Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell (2007) 16.66
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
DNA copy number losses in human neoplasms. Am J Pathol (1999) 2.73
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci U S A (2002) 2.62
Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res (2012) 2.45
Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res (2008) 2.22
Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74
CTCF shapes chromatin by multiple mechanisms: the impact of 20 years of CTCF research on understanding the workings of chromatin. Chromosoma (2010) 1.56
Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol (2000) 1.53
Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF. Mol Cell Biol (2001) 1.48
Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res (2011) 1.38
Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol (2006) 1.24
Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog (2011) 1.16
Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta (2009) 1.12
CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer. Cell Rep (2014) 1.11
Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis. J Cell Mol Med (2006) 1.11
Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions. J Virol (2009) 1.03
Functional role of CCCTC binding factor (CTCF) in stress-induced apoptosis. Exp Cell Res (2007) 0.99
Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas. Am J Pathol (2000) 0.94
Pax6 regulation in retinal cells by CCCTC binding factor. Invest Ophthalmol Vis Sci (2006) 0.94
Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites. J Immunol (2007) 0.93
Loss of maternal CTCF is associated with peri-implantation lethality of Ctcf null embryos. PLoS One (2012) 0.91
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nat Cell Biol (2012) 0.89
Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity. Curr Genomics (2009) 0.87
Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis. PLoS Genet (2008) 0.85
BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma. Genet Test Mol Biomarkers (2012) 0.82
Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1. Br J Cancer (2004) 0.81
Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis. J Clin Pathol (2007) 0.80
Regulation of disease-associated gene expression in the 3D genome. Nat Rev Mol Cell Biol (2016) 0.80
Targeted tumor gene therapy based on loss of IGF2 imprinting. Cancer Biol Ther (2010) 0.79
Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy. Br J Cancer (2005) 0.79
Restraint of angiogenesis by zinc finger transcription factor CTCF-dependent chromatin insulation. Proc Natl Acad Sci U S A (2011) 0.79
CTCF mediates effect of insulin on glucagon expression. Exp Cell Res (2012) 0.79
The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer. DNA Cell Biol (2014) 0.77
CCCTC-binding factor mediates effects of glucose on beta cell survival. Cell Prolif (2013) 0.77
A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer. Breast Cancer Res (2004) 0.77
The three-dimensional cancer genome. Curr Opin Genet Dev (2016) 0.76
CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic. Oncogene (2017) 0.75
A rapid and simple method for the isolation of high molecular weight cellular and chromosome-specific DNA in solution without the use of organic solvents. Nucleic Acids Res (1987) 33.75
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (1977) 12.57
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A (1978) 9.59
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A (1980) 6.65
An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol (1996) 5.74
Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr Biol (2000) 5.34
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Comparison of human genetic and sequence-based physical maps. Nature (2001) 4.97
Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (1985) 4.35
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5'-flanking sequence of the chicken c-myc gene. Oncogene (1990) 3.96
Expression of the c-myb proto-oncogene during cellular proliferation. Nature (1986) 3.45
Bone-marrow transplantation (first of two parts). N Engl J Med (1975) 3.33
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol Cell Biol (1993) 3.08
Measurement of endogenous leukosis virus nucleotide sequences in the DNA of normal avian embryos by RNA-DNA hybridization. Virology (1973) 2.94
CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat Genet (2001) 2.93
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med (1979) 2.80
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Nucleotide sequence relationships of avian RNA tumor viruses: measurement of the deletion in a transformation-defective mutant of Rous sarcoma virus. J Virol (1974) 2.61
Physical mapping of human chromosomes by repetitive sequence fingerprinting. Proc Natl Acad Sci U S A (1990) 2.57
The relationship between chromosome structure and function at a human telomeric region. Nat Genet (1997) 2.48
Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood (1981) 2.16
Somatic diversification of the chicken immunoglobulin light chain gene is limited to the rearranged variable gene segment. Cell (1987) 2.15
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci U S A (1983) 2.08
A case for evolutionary genomics and the comprehensive examination of sequence biodiversity. Mol Biol Evol (2000) 2.07
Two distinct candidate transforming genes of lymphoid leukosis virus-induced neoplasms. Nature (1981) 2.03
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci U S A (1997) 2.01
Rous sarcoma virus nucleotide sequences in cellular DNA: measurement by RNA-DNA hybridization. Science (1972) 2.00
Efficient pooling designs for library screening. Genomics (1995) 1.97
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci U S A (1985) 1.94
Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet (1996) 1.93
Transforming genes of neoplasms induced by avian lymphoid leukosis viruses. Nature (1980) 1.90
Molecular cloning and nucleotide sequence of a transforming gene detected by transfection of chicken B-cell lymphoma DNA. Nature (1983) 1.88
Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat (1997) 1.88
A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J Biol Chem (1991) 1.83
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood (1997) 1.71
Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. Hum Mol Genet (1997) 1.70
Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res (2001) 1.69
11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2009) 1.66
Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med (1971) 1.65
A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci U S A (1993) 1.63
Isolation and molecular characterization of a highly polymorphic centromeric tandem repeat in the family Falconidae. Genomics (1988) 1.63
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J Biol Chem (1999) 1.62
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells. Int J Cancer (1980) 1.61
Infection of chick cells by subgroup E viruses. Virology (1976) 1.60
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant (2010) 1.59
The effect of alterations in myc gene expression on B cell development in the bursa of Fabricius. Cell (1987) 1.57
Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell (1994) 1.56
Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55
Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (1994) 1.51
Base-sequence relationships between avian ribonucleic acid endogenous and sarcoma viruses assayed by competitive ribonucleic acid-deoxyribonucleic acid hybridization. Biochemistry (1974) 1.50
Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF. Mol Cell Biol (2001) 1.48
A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev (1992) 1.44
Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (1979) 1.44
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science (1984) 1.44
Characterisation of chicken erythroid nuclear proteins which bind to the nuclease hypersensitive regions upstream of the beta A- and beta H-globin genes. Nucleic Acids Res (1986) 1.43
Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF. Cancer Res (2001) 1.42
All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood (2000) 1.39
Aplastic anaemia treated by marrow transplantation. Lancet (1972) 1.39
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut (2002) 1.38
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
Organization of shared and unshared sequences in the genomes of chicken endogenous and sarcoma viruses. Cell (1977) 1.36
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36
Replacement of serum by insulin and transferrin supports growth and differentiation of the human promyelocytic cell line, HL-60. Exp Cell Res (1980) 1.35
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34
Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet (2001) 1.32
Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32
Construction of a BAC contig map of chromosome 16q by two-dimensional overgo hybridization. Genome Res (2000) 1.32
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ (1995) 1.30
A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics (1998) 1.30
An integrated physical map of human chromosome 16. Nature (1995) 1.29
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia (2013) 1.27
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry (2001) 1.26
Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF. J Biol Chem (2000) 1.26